BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35717355)

  • 1. Amputation and infection are the greatest fears in patients with diabetes foot complications.
    Wukich DK; Raspovic KM; Jupiter DC; Heineman N; Ahn J; Johnson MJ; Liu GT; VanPelt MD; Lafontaine J; Lavery L; Kim P; Nakonezny PA
    J Diabetes Complications; 2022 Jul; 36(7):108222. PubMed ID: 35717355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death.
    Wukich DK; Raspovic KM; Suder NC
    Foot Ankle Spec; 2018 Feb; 11(1):17-21. PubMed ID: 28817962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mid-Term Outcomes of Reconstruction of Charcot Foot Neuroarthropathy in Diabetic Patients].
    Kučera T; Grinac M; Valtr O; Šponer P
    Acta Chir Orthop Traumatol Cech; 2019; 86(1):51-57. PubMed ID: 30843514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer.
    Sohn MW; Stuck RM; Pinzur M; Lee TA; Budiman-Mak E
    Diabetes Care; 2010 Jan; 33(1):98-100. PubMed ID: 19825822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Difference in Risk of Amputation or Frequency of Surgical Interventions Between Patients With Diabetic and Nondiabetic Charcot Arthropathy.
    Waibel FWA; Weber S; Selman F; Götschi T; Berli MC; Böni T; Schöni M
    Clin Orthop Relat Res; 2023 Aug; 481(8):1560-1568. PubMed ID: 36692512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amputation and mortality frequencies associated with diabetic Charcot foot arthropathy: a meta-analysis.
    Yammine K; Boulos K; Assi C; Hayek F
    Foot Ankle Surg; 2022 Dec; 28(8):1170-1176. PubMed ID: 36028441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications from ankle arthrodesis in diabetes-related Charcot foot syndrome.
    Wang BK; Wukich DK; Sambandam S
    J Diabetes Complications; 2021 Dec; 35(12):108071. PubMed ID: 34674895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic charcot neuroarthropathy of the foot and ankle with osteomyelitis.
    Ramanujam CL; Stapleton JJ; Zgonis T
    Clin Podiatr Med Surg; 2014 Oct; 31(4):487-92. PubMed ID: 25281510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Diabetic Charcot Patients With and Without Foot Wounds.
    Wukich DK; Sadoskas D; Vaudreuil NJ; Fourman M
    Foot Ankle Int; 2017 Feb; 38(2):140-148. PubMed ID: 27923212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated With Major Lower Extremity Amputation After Osseous Diabetic Charcot Reconstruction.
    Elmarsafi T; Anghel EL; Sinkin J; Cooper PS; Steinberg JS; Evans KK; Kim PJ; Attinger CE
    J Foot Ankle Surg; 2019 Mar; 58(2):295-300. PubMed ID: 30850098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal Amputation in Charcot Neuroarthropathy Complicated by Diabetic Foot Osteomyelitis.
    Consul D; So E; Shah N; Logan D
    J Foot Ankle Surg; 2020; 59(4):853-856. PubMed ID: 32279895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel FEMASK-score, a histopathologic assessment for destructive Charcot neuropathic arthropathy, reveals intraneural vasculopathy and correlates with progression and best treatment.
    King J; Murie B; Fanburg-Smith JC; Stauch CM; Flemming D; Klein MJ; Frauenhoffer EE; Fritsche M; Smith JD; Elfar J; Aynardi M
    Ann Diagn Pathol; 2020 Aug; 47():151509. PubMed ID: 32619921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soft Tissue Reconstruction Pyramid for the Diabetic Charcot Foot.
    Capobianco CM; Zgonis T
    Clin Podiatr Med Surg; 2017 Jan; 34(1):69-76. PubMed ID: 27865316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of limb preservation status and body mass index on the survival of patients with limb-threatening diabetic foot ulcers.
    Lin CW; Hsu BR; Tsai JS; Yang HM; Lin JR; Lin CH; Huang CH; Hung SY; Huang YY
    J Diabetes Complications; 2017 Jan; 31(1):180-185. PubMed ID: 27751708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.
    Schmidt BM; Holmes CM
    Curr Diab Rep; 2018 Aug; 18(10):74. PubMed ID: 30112582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term predictors of amputation in patients with diabetic foot ulcers.
    Ferreira L; Carvalho A; Carvalho R
    Diabetes Metab Syndr; 2018 Nov; 12(6):875-879. PubMed ID: 29802073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Charcot Neuroarthropathy in Diabetic Patients who Received Kidney or Kidney-Pancreas Transplants.
    Anthony ML; Cravey KS; Atway SA
    J Foot Ankle Surg; 2019 May; 58(3):475-479. PubMed ID: 30765253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous surgical repair of a tibialis anterior tendon rupture and diabetic charcot neuroarthropathy of the midfoot: a case report.
    Stapleton JJ
    Clin Podiatr Med Surg; 2013 Oct; 30(4):599-604. PubMed ID: 24075138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative Management of Charcot Neuroarthropathy.
    Schweitzer M; Rockhill S
    Clin Podiatr Med Surg; 2022 Oct; 39(4):585-594. PubMed ID: 36180190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.